OTCBB:PMCB

Pharmacyt Biotch Stock Predictions

Healthcare > Biotechnology

Buy PMCB

*Your capital is at risk

$0.751

-0.0489 (-6.11%)

At Close: Jun 02, 2026

Currently predicting for Thu, 4 Jun 2026

PMCB Prediction Chart

PMCB Predictions History

Latest community submissions for PMCB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Sep 13, 2021	$3.52 +3.23%	$3.41	X	96.77%	1
www.rkomar315.252934	Sep 13, 2021	Bullish	$3.41	X	—	0
Russ Martin @RussMartin.231026	Sep 13, 2021	Bullish	$3.41	X	—	0
RamboRex3000 Pro	Aug 20, 2021	$3.37 -3.16%	$3.48	X	96.84%	0
RamboRex3000 Pro	Aug 19, 2021	$10.15 +191.67% Unrealistic Excluded from avg	$3.48	X	0.00%	0
NameNotImportant Pro	May 6, 2019	$0.0410 -99.93%	$0.0406	X	99.01%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PMCB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PHARMACYT BIOTCH

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by